Core/Shell nanoparticles for ph-sensitive delivery of doxorubicin

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 10, 2010, Pages 6967-6971

  Oh, Keun Sang ^a   Um, Yun Sik ^a   Lee, Jin Ho ^a   Cho, Sun Hang ^b   Lee, Kyung Eun ^c   Han, Sung Sik ^c   Kim, Dongmin ^d   Yuk, Soon Hong ^a  

^a Hannam University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c Korea University   (South Korea)

^d Hong Ik University   (South Korea)

Author keywords

Core Shell Nanoparticles with Drug Loaded Lipid Cores; Doxorubicin; Lecithin; pH Sensitive Release of Anticancer Drug; Pluronics

Indexed keywords

DOXORUBICIN; LECITHIN; LIPID CORES; PH SENSITIVE RELEASE OF ANTICANCER DRUG; PLURONICS;

BLOCK COPOLYMERS; DRUG DELIVERY; DRUG PRODUCTS; ETHYLENE; PH SENSORS; PHOSPHOLIPIDS; POLYETHYLENE OXIDES; PROPYLENE;

NANOPARTICLES;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; NANOPARTICLE; PHOSPHATIDYLCHOLINE; POLOXAMER; TREHALOSE;

ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; METHODOLOGY; PARTICLE SIZE; PH; TRANSMISSION ELECTRON MICROSCOPY;

ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; LECITHINS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POLOXAMER; TREHALOSE;

EID: 79952197752     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.2986     Document Type: Conference Paper

References (21)

1. S. Kim, M. S. Turker, E. Y. Chi, S. Sela, and G. M. Martin, Biochim. Biophys. Acta 728, 339 (1983).
2. I. C. Kwon, Y. H. Bae, T. Okano, B. Bemer, and S. W. Kim, Macromol. Chem. Macromol. Symp. 33, 265 (1990).
3. S. H. Yuk and Y H. Bae, Critical Reviews in Therapeutic Drug Carrier Systems 16, 385 (1999).
4. E. J. Kim, S. H. Cho, and S. H. Yuk, Biomaterials 22, 2495 (2001).
5. J. H. Kim, Y S. Kim, S. Kim, J. H. Park, K. Kim, K. Choi, H. Chung, R. W. Park, I. S. Kim, and I. C. Kwon, J. Controlled Release 111, 228 (2006).
6. L. Zhang, L. Hong, Y Yu, S. C. Bae, and S. Granik, J. Am. Chem. Soc. 128, 9026 (2006).
7. G. S. Kwon, Critical Reviews in Therapeutic Drug Carrier Systems 20, 357 (2003).
8. H. Otsuka, Y. Nagasaki, and K. Kataoka, Adv Drug Delivery Rev. 55, 403 (2003).
9. N. Nasongkla, E. Bey, J. Ren, H. Ai, C. Khemtong, J. S. Guthi, S. F. Chin, A. D. Sherry, D. A. Boothman, and J. Gao, Nano Lett. 11, 2427 (2006).
10. L. S. Lee, H. J. Shin, K. Na, and Y. H. Bae, J. Controlled Release 90, 363(2003).
11. H. S. Yoo and T. G. Park, J. Controlled Release 96, 273 (2004).
12. Y. Matsumura and H. Maeda, Cancer Research 46, 6387 (1986).
13. S. Danson, D. Ferry, V. Alakhov, J. Margison, D. Kerr, D. Jowle, M. Brampton, G. Halbert, and M. Ranson, Br. J. Cancer 90, 2085 (2004).
14. Y Matsumura, T. Hamaguchi, T. Ura, K. Muro, Y. Yamada, Y Shimada, K. Shirao, T. Okusaka, H. Ueno, M. Ikeda, and N. Watanabe, Br. J. Cancer 91, 1775 (2004).
15. I. F. Tannok and D. Rotin, Cancer Res. 49, 4373 (1989).
16. K. Engin, D. B. Leeper, J. R. Cater, A. J. Thistlethwaite, L. Tupchong, and J. D. MacFarlane, Int. J. Hyperthermia 11, 211 (1995).
17. E. S. Lee, K. Na, and Y. H. Bae, Nano Lett. 5, 325 (2005).
18. K. S. Oh, K. Y Lee, S. S. Han, S. H. Cho, D. Kim, and S. H. Yuk, Biomacromolecules 6, 1062 (2005).
19. K. S. Oh, S. K. Han, H. S. Lee, H. M. Koo, R. S. Kim, K. Y Lee, S. S. Han, S. H. Cho, and S. H. Yuk, Biomacromolecules 7, 2362 (2006).
20. G. Monatalov and A. Khan, Langmuir 18, 8330 (2002).
21. J. K. Kaushik and B. Bhat, J. Biol. Chem. 278, 26458 (2003).